Skip to main content
Quest Diagnostics

Variants of Unknown Significance in Maturity-Onset Diabetes of the Young: High Rate of Conundrum Resolution via Variants of Unknown Significance Reanalysis

Variants of Unknown Significance in Maturity-Onset Diabetes of the Young: High Rate of Conundrum Resolution via Variants of Unknown Significance Reanalysis

Authors: Alarcon G, Maston GA, Hoffman CA, Posey JE, Redondo MJ, Tosur M

Citation: Horm Res Paediatr. 2024 May 28:1-8. doi: 10.1159/000539542. Epub ahead of print.

Specialties: Cardiology, Endocrinology, Genetics, Pediatrics

Disclaimer: One or more of the authors of this publication were employed at the time by Athena Diagnostics, a subsidiary of Quest Diagnostics.

Related content

Conference Presentation
Fasting Intact Insulin by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) as a Predictor of Nonalcoholic Fatty Liver Disease in Pediatric Patients
Audio Podcast
Instant Insight: Metabolic Risk Panel
On-Demand Webinar
Early Identification of Type 2 Diabetes Risk for the Primary Care Setting

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.